Wednesday, January 29, 2020

News / DT 8 / 2011

GAVI funds big pharma while Indian drug firm could produce for less

Donors recently committed USD 4.3 billion in new support to GAVI; a third of this will finance the purchase of pneumococcal vaccine. While critics say that GAVI is paying too much for pneumo vaccine, the head of the Indian firm Serum Institute says he will have a pneumonia vaccine on the market by 2015 at a fraction of what GAVI is currently paying big pharma.

Heidi Hautala named new Finnish aid minister

Finland’s new government is finally taking shape after two months of political horse-trading following the parliamentary elections April 17. The new government has agreed on a preliminary programme, and Heidi Hautala (Greens) takes over the aid portfolio.

Donors continue to hold back support from Global Fund

Several donors to the Global Fund continue to hold back their contributions for this year. Some have yet to make pledges; others have frozen disbursements pending the outcomes of two on-going reviews of corruption. The result is that amounts pledged so far for 2011 are USD 645 million short of last year’s total.

Norway scales back funding of Clinton foundation

Norway, a top donor of former President Bill Clinton’s foundation, has decided not to enter into a new cooperation agreement with the charity. The foundation can still apply for Norwegian funding on a project basis, but Norway will tone down the high political profile of the prestigious cooperation.

NGO report documents EU donors’ broken aid promises

EU member states have fallen far behind their aid targets, says Aidwatch. Last year they spent EUR 15 billion less than their collective commitment, and 10 per cent of the money spent in 2010 was “inflated aid”.

New billions to GAVI for vaccine roll out

International donors, led by the United Kingdom, the Gates Foundation and Norway, have pledged USD 4.3 billion to the Global Alliance for Vaccines and Immunisation (GAVI), exceeding the agency’s fund-raising target by USD 600 million.